For 40 years, we have been producing and investing in Poland and we will continue to increase our capacities in the country. Over the past five years, we have increased our pharmaceutical production by 75%. At the same time, we are developing our production network in several locations. In the current geopolitical situation, this enhances the security of supply for patients and the company's resilience to crises – says Małgorzata Adamkiewicz, chairwoman of the supervisory board and co-owner of Adamed Pharma. #AdamedPharma #ProdukcjaLeków #InwestycjeWPolsce (translated)
Adamed plans to double its production capacity, investing over 100 million euros in a plant in Spain and 700 million PLN in Poland by 2030, including building an inhaled medication factory in Pabianice. #AdamedPharma #ProdukcjaLeków #InwestycjeWPolsce (translated)
